Paul Hastings (Washington)

Noah Pinegar

Paul Hastings (Washington)
Associate

Noah Pinegar in an associate in the Antitrust and Competition practice of Paul Hastings and is based in the firm’s Washington, D.C. office. Mr. Pinegar represents clients in merger reviews before the Federal Trade Commission, the U.S. Department of Justice, and international enforcers, as well as in civil and criminal investigations and litigation. During his time as an attorney with the Federal Trade Commission, Mergers I division, Mr. Pinegar was a member of multiple litigation/trial teams, including FTC v. Staples/Office Depot, and high-profile investigations in industries such as pharmaceuticals, medical devices, pharmacies, and pharmacy benefit management.

Linked authors

Paul Hastings (Paris)
Paul Hastings (San Francisco)
Paul Hastings (San Diego)
Paul Hastings (San Francisco)
Paul Hastings (Washington)

Articles

139 Bulletin

Michael Cohen, Noah Pinegar The US District Court for the Eastern District of New York holds that Chinese law did not compel the defendants in a cartel case to reach agreements on price and output (In re Vitamin C Antitrust Litigation)

139

In a recent, strongly worded federal antitrust decision, pleas for international comity by China’s nationalized vitamin industry and its regulatory overseer, China’s foremost trade industry, fell short in a showdown with U.S. domestic antitrust laws. The case indicates that foreign compulsion (...)

6621 Review

Alden F. Abbott, Robin Adelstein, Megan Browdie, Michael A. Carrier, Peter C. Carstensen, Samuel Clark, Lisl J. Dunlop, Harry First, Albert A. Foer, Eleanor M. Fox, Jacqueline Grise, Ryan Kantor, Donald C. Klawiter, John Kwoka, James Langenfeld, Tad Lipsky, Alessandro Massolo, Howard Morse, Gabriella Muscolo, James Bo Pearl, Noah Pinegar, Chris Ring, Christopher Sagers, Richard S. Taffet, Willard K. Tom, Eliot Turner, Doug Tween, Tommaso Valletti, Michael L. Weiner The new US antitrust administration

6621

This Concurrences special set of articles focuses on antitrust law and enforcement in the aftermath of the American Presidential Elections. It questions the changes and challenges expected in 2021 under the new Biden administration, and its impacts with respect to antitrust legislation and (...)

Send a message